Supplemental material
Modern Rheumatology
Volume 25, 2015 - Issue 4
Open access
3,631
Views
104
CrossRef citations to date
0
Altmetric
Original Articles
Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, JapanCorrespondence[email protected]
, Tsutomu TakeuchiKeio University, Tokyo, Japan
, Hisashi YamanakaTokyo Women's Medical University, Tokyo, Japan
, Hiroyuki NakamuraPfizer Japan Inc, Tokyo, Japan
, Shigeyuki ToyoizumiPfizer Japan Inc, Tokyo, Japan
& Samuel ZwillichPfizer Inc, Groton, CT, USA
Pages 514-521
|
Received 26 Sep 2014, Accepted 30 Nov 2014, Published online: 11 Dec 2014
Related Research Data
Long-term inhibition of radiographic joint damage by tofacitinib monotherapy in rheumatoid arthritis patients with rapid radiographic progression about eight cases
Source:
Informa UK Limited
Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study
Source:
Springer Science and Business Media LLC
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
Source:
Springer Nature
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Source:
Massachusetts Medical Society
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis
Source:
Springer Science and Business Media LLC
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.
Source:
Wiley
Risk of Herpes Zoster in Individuals on Biologics, Disease-Modifying Antirheumatic Drugs, and/or Corticosteroids for Autoimmune Diseases: A Systematic Review and Meta-Analysis
Source:
Oxford University Press (OUP)
Comparison of Janus kinase inhibitors in the treatment of rheumatoid arthritis: a systemic literature review.
Source:
Future Medicine Ltd
Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
Source:
Informa UK Limited
Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
Source:
Informa UK Limited
Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data
Source:
Informa UK Limited
Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.
Source:
Springer Science and Business Media LLC
Guidelines for the proper use of etanercept in Japan.
Source:
Oxford University Press (OUP)
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
Source:
Oxford University Press (OUP)
Are Janus Kinase Inhibitors Superior over Classic Biologic Agents in RA Patients
Source:
Hindawi Limited
RISK OF HZ WITH TOFACITINIB AND CONCOMITANT THERAPY
Source:
Wiley
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.